Prevalence and Patterns of Hearing Loss Among Chronic Kidney Disease Patients Undergoing Haemodialysis

Jamaldeen, Jishana; Basheer, Aneesh; Sarma, Akhil Chandra; Ravichandran, K.

doi:10.21767/amj.2015.2258

Cited by 12 publications

(18 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3,4 Meena et al, reported incidence of moderately severe to severe degree of hearing loss in upto 28% while Pandey et al found that 78.25% of hearing loss in patients with CRF. 17,18 In our study, prevalence of disease increased with the age and similar finding were found in other study like Hill et al, Jamaldeen et al, Vilayur et al [19][20][21] We performed distribution of hearing loss both in diseased and controls. Out of 50 cases, 45 (90%) patients lie in low frequency range, and out of which, maximum patients 18 (40%) lie in the range of moderate degree of hearing loss, whereas in controls maximum patients 8 (63%) lie in the range of mild degree of hearing loss.…”

Section: Discussionsupporting

confidence: 88%

Hearing assessment in chronic kidney disease patients: a cross-sectional study

Jain

Upadhyay

Aftab

et al. 2020

Int J Otorhinolaryngol Head Neck Surg

View full text Add to dashboard Cite

Background: It is well known that chronic kidney disease (CKD) causes different systemic and otorhinolaryngologic manifestations due to the accumulation of waste products, osmotic alteration, and antigenic similarity between basement membrane of the glomerulus and stria vascularis of the inner ear. Methods: The study subjects were divided into two groups, 50 CKD patients and 50 healthy volunteers in age group 15-60 years. All CKD patients and controls were subjected to hearing assessment using standard pure tone audiometry. Results: For low frequency hearing loss increased from stage 2 and 3 to stage 4 and 5, and for high frequency hearing loss among stage 2 and 3 CKD patients was mild to moderate (65.22%) in nature and hearing loss increased in intensity (i.e. severe to profound) in stage 4 and 5 of CKD patients. Dialysis patients were having more severe hearing loss in comparison to non dialysis patients. Hearing loss was negatively correlated with the eGFR. And positively correlated with the duration of the disease (CKD).Conclusions: Our study highlights the pattern of hearing loss in people suffering from chronic kidney disease who were either on dialysis or not on dialysis. Early identification can prevent further deterioration of hearing in patients suffering from chronic kidney disease.

show abstract

Section: Discussionsupporting

confidence: 88%

Hearing assessment in chronic kidney disease patients: a cross-sectional study

Jain

Upadhyay

Aftab

et al. 2020

Int J Otorhinolaryngol Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…However, several potential mechanisms may underly such association. Hearing loss was found to be highly prevalent among CKD patients [36,37], and increasing serum creatinine or blood pressure was found associated with increasing hearing threshold [38]. Several similarities between cochlea and kidney can be observed, including membranous structures, the central role of ciliated epithelial cells, and tubular organization [39].…”

Section: Discussionmentioning

confidence: 99%

Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance

et al. 2020

View full text Add to dashboard Cite

Background Chronic kidney disease (CKD) is known to be associated with several co-occurring conditions. We aimed at exploring multimorbidity patterns associated with CKD, as well as the impact of physical performance and CKD severity on them in a population of older outpatients. Methods Our series consisted of 2252 patients enrolled in the Screening of CKD among Older People across Europe multicenter observational study. Hypertension, stroke, transient ischemic attack, cancer, hip fracture, osteoporosis, Parkinson’s disease, asthma, chronic obstructive pulmonary disease, congestive heart failure, angina, myocardial infarction, atrial fibrillation, anemia, CKD (defined as GFR < 60, < 45 or < 30 ml/min/1.73 m2), cognitive impairment, depression, hearing impairment and vision impairment were included in the analyses. Physical performance was assessed by the Short Physical Performance Battery (SPPB) and used as stratification variable. Pairs of co-occurring diseases were analyzed by logistic regression. Patterns of multimorbidity were investigated by hierarchical cluster analysis. Results CKD was among the most frequently observed conditions and it was rarely observed without any other co-occurring disease. CKD was significantly associated with hypertension, anemia, heart failure, atrial fibrillation, myocardial infarction and hip fracture. When stratifying by SPPB, CKD was also significantly associated with vision impairment in SPPB = 5–8 group, and hearing impairment in SPPB = 0–4 group. Cluster analysis individuated two main clusters, one including CKD, hypertension and sensory impairments, and the second including all other conditions. Stratifying by SPPB, CKD contribute to a cluster including diabetes, anemia, osteoporosis, hypertension and sensory impairments in the SPPB = 0–4 group. When defining CKD as eGFR< 45 or 30 ml/min/1.73 m2, the strength of the association of CKD with hypertension, sensory impairments, osteoporosis, anemia and CHF increased together with CKD severity in pairs analysis. Severe CKD (eGFR< 30 ml/min/1.73 m2) contributed to a wide cluster including cardiovascular, respiratory and neurologic diseases, as well as osteoporosis, hip fracture and cancer. Conclusions CKD and its severity may contribute significantly to specific multimorbidity patterns, at least based on the cluster analysis. Physical performance as assessed by SPPB may be associated with not negligible changes in both co-occurring pairs and multimorbidity clusters. Trial registration The SCOPE study is registered at clinicaltrials.gov (NCT02691546).

show abstract

“…18 The patients' hearing threshold was classified as follows: normal threshold (25 dB HL), mild hearing loss (26-40 dB HL), moderate hearing loss (41-55 dB HL), moderately severe hearing loss (56-70 dB HL), severe hearing loss (71-91 dB HL), and profound hearing loss (>91 dB HL). 19 A hearing threshold of 25 dB HL was considered normal, and a hearing threshold of >25 dB HL was considered abnormal. All data were collated and analyzed using IBM SPSS Statistics for Windows, Version 20.0 (IBM Corp., Armonk, NY, USA).…”

Section: Methodsmentioning

confidence: 99%

Otological manifestation of temporomandibular joint disorder in Ekiti, a sub-Saharan African country

et al. 2021

View full text Add to dashboard Cite

Objective To determine the prevalence, sociodemographic features, and clinical presentation of temporomandibular joint disorder in otorhinolaryngological practice. Methods This prospective hospital-based study involved patients diagnosed with temporomandibular joint disorder in our institution’s ear, nose, and throat department. Data for this study were obtained from the patients using pretested interviewer-assisted questionnaires. Results The prevalence of temporomandibular joint disorder in this study was 1.3%. The study population included 17 (26.2%) male patients with a male:female ratio of 1.0:2.8. Joint disorder accounted for 75.4% of all disorders, while both mastication muscle and joint disorder accounted for 21.5%. A majority of the patients (47.7%) presented between weeks 1 and 13 of the illness. Unilateral temporomandibular joint disorder accounted for 98.5% of all disorders. The main otologic clinical features were earache and a dull tympanic membrane in 100% and 35.4% of patients, respectively. Middle ear assessment revealed type A in 73.8% of patients and type B in 20.0% according to Jerger’s classification system of tympanometry. Most patients (81.5%) were referred by their family physician. All patients had undergone prehospital treatment prior to presentation. Conclusion Temporomandibular joint disorder is a common presentation in medical practice. Common clinical features include ear, joint, and mastication muscle disorders.

show abstract

Prevalence and Patterns of Hearing Loss Among Chronic Kidney Disease Patients Undergoing Haemodialysis

Cited by 12 publications

References 0 publications

Hearing assessment in chronic kidney disease patients: a cross-sectional study

Hearing assessment in chronic kidney disease patients: a cross-sectional study

Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance

Otological manifestation of temporomandibular joint disorder in Ekiti, a sub-Saharan African country

Contact Info

Product

Resources

About